Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
August 2013 Vol 6, No 6 Special Issue
Health Policy and Reform
FDA Expected to Approve Surrogate End Point for Neoadjuvant Breast Cancer Trials
Caroline Helwick
Read More
Lung Cancer
Crizotinib Superior to Standard Chemotherapy in ALK-Positive Lung Cancer
Read More
Drug Updates
Xofigo (Radium Ra 223 Dichloride): The First Alpha Particle–Emitting Radioactive Agent for the Treatment of Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases
Lisa A. Raedler, PhD, RPh
Read More
Payers' Perspectives
Cancer Care in 2013: Hope, Reality, and a Call to Action
Gary M. Owens, MD
Read More
Experts Debate Value of Bevacizumab in Newly Diagnosed Glioblastoma
Audrey Andrews
Read More
Bevacizumab an Effective New Treatment Option for Relapsed Cervical Cancer
Wayne Kuznar
Read More
Sorafenib Effective in Metastatic Differentiated Thyroid Cancer
Audrey Andrews
Read More
Prostate Cancer
New Analysis Confirms Radium Ra-223 Prolongs Survival in Patients with Metastatic CRPC, Regardless of Previous Docetaxel Therapy Status
Wayne Kuznar
Read More
Prostate Cancer
Lack of Knowledge Prevents Men with Early-Stage Prostate Cancer from Choosing Active Surveillance
Wayne Kuznar
Read More
Breast Cancer
New Data Confirm Benefits of 10 Years Tamoxifen versus 5 Years in Patients with ER-Positive Breast Cancer
Wayne Kuznar
Read More
1
2
3
4
Page 1 of 4
Results 1 - 10 of 34